凝固検査市場：製品タイプ別、検査タイプ別、エンドユーザー別-2024～2030年の世界予測

凝固検査市場規模は、2023年に46億2,000万米ドルと推計され、2024年には50億7,000万米ドルに達し、CAGR 9.92％で2030年には89億6,000万米ドルに達すると予測されています。

凝固検査には、血液を適切に凝固させる能力を評価することを目的とした一連の診断手順が含まれます。これらの検査は、血友病、血栓症、肝疾患など、血液凝固能に影響を及ぼす様々な疾患の診断と管理に不可欠です。また、抗凝固療法を受けている患者をモニタリングし、安全で効果的な治療結果を確保するためにも不可欠です。心血管疾患や血液疾患の有病率の上昇により、凝固検査の採用が増加しています。さらに、血液関連疾患のリスクが高い世界人口の高齢化も、凝固検査の必要性を著しく高めています。しかし、凝固検査デバイスのコストが高く、新しいデバイスの承認に対する規制要件が厳しいため、製品の発売が遅れ、市場力学に影響を与えています。このような課題にもかかわらず、新興国ではヘルスケアインフラへの投資が増加しており、今後の成長が期待されています。さらに、革新的で効率的なKEYWORDソリューションの導入を目指した研究開発活動も進行しており、新たな拡大への道筋が期待されます。

製品凝固検査における効率性と拡張性を実現する自動化機器の導入が増加

凝固検査における消耗品には、試薬、テストストリップ、その他凝固検査に不可欠な使い捨て材料が含まれます。これらは血液凝固時間、因子、その他の関連パラメータを正確に検出・測定するために不可欠です。凝固検査装置は、基本的な手動装置から完全自動化システムまで多岐にわたります。これらの機器はプロトロンビン時間（PT）、活性化部分トロンボプラスチン時間（aPTT）など様々な検査に使用されます。手動システムか自動システムかの選択は、一般に検査室が行う検査量と必要とする検査の複雑さに基づいています。

エンドユーザー：遠隔患者モニタリングをサポートする家庭用凝固検査キットの採用拡大

臨床検査室は、凝固検査市場において重要なセグメントを占めています。これらの施設では、様々な出血性疾患や凝固性疾患に対して正確で信頼性の高い診断サービスを提供するために、包括的で高度な凝固検査ソリューションが必要とされています。臨床検査室では、大量の検体を効率的に処理できる高スループットの凝固分析装置が好まれています。凝固検査における在宅検査ソリューションの需要は、患者中心の医療が重視されるようになり、抗凝固療法を受けている患者の継続的モニタリングの必要性が高まったことが背景にあります。在宅検査キットは、利便性と日常生活への最小限の支障を求める患者にとって魅力的です。病院では、救急治療室から凝固専門クリニックまで、さまざまな部門のニーズに対応するため、多様な凝固検査機能を必要としています。この分野では、急性期医療の現場で迅速な意思決定を可能にする汎用性の高い迅速な凝固分析装置が好まれています。

地域別インサイト

南北アメリカでは、特に北米で心血管疾患の有病率が高く、高齢化も進んでいることから、凝固検査の採用が進んでいます。米国は、先進的なヘルスケアインフラと有利な償還政策に支えられ、高い採用率を示しています。EMEA地域は凝固検査市場において多様なシナリオを提示しており、欧州は高い採用率を示しています。欧州の成長に拍車をかけているのは、より迅速で効率的な診断のためにPOC（ポイント・オブ・ケア）検査機器の導入が進んでいることに加え、強固なヘルスケアシステムと患者の意識の高さです。中東とアフリカは、ヘルスケア施設を改善するための政府やNGOのイニシアティブにより、緩やかな成長を遂げています。アジア太平洋は凝固検査の最大市場になると予測され、その原動力は急速に発展するヘルスケア・インフラと大規模な患者プールです。中国やインドをはじめとする国々では、中流階級の人口が増加し、ヘルスケア改革への関心が高まっていることから、凝固検査の採用が最前線に進んでいます。さらに、手ごろな価格の検査ソリューションを開発するための研究開発活動がこの地域で拡大していることも、この地域の市場を押し上げると予想されます。

FPNVポジショニング・マトリックス

FPNVポジショニングマトリックスは凝固検査市場の評価において極めて重要です。事業戦略や製品満足度に関連する主要指標を調査し、ベンダーの包括的な評価を提供します。この綿密な分析により、ユーザーは各自の要件に沿った十分な情報に基づいた意思決定を行うことができます。評価に基づき、ベンダーは成功の度合いが異なる4つの象限に分類されます：フォアフロント（F）、パスファインダー（P）、ニッチ（N）、バイタル（V）です。

市場シェア分析

市場シェア分析は、凝固検査市場におけるベンダーの現状について、洞察に満ちた詳細な調査を提供する包括的なツールです。全体的な収益、顧客基盤、その他の主要指標についてベンダーの貢献度を綿密に比較・分析することで、企業の業績や市場シェア争いの際に直面する課題について理解を深めることができます。さらに、この分析により、調査対象基準年に観察された累積、断片化の優位性、合併の特徴などの要因を含む、この分野の競合特性に関する貴重な考察が得られます。このような詳細レベルの拡大により、ベンダーはより多くの情報に基づいた意思決定を行い、市場で競争優位に立つための効果的な戦略を考案することができます。

本レポートは、以下の側面に関する貴重な洞察を提供しています：

1.市場の浸透度：主要企業が提供する市場に関する包括的な情報を提示しています。

2.市場の開拓度：有利な新興市場を深く掘り下げ、成熟市場セグメントにおける浸透度を分析しています。

3.市場の多様化：新製品の発売、未開拓の地域、最近の開発、投資に関する詳細な情報を提供します。

4.競合の評価と情報：市場シェア、戦略、製品、認証、規制状況、特許状況、主要企業の製造能力などを網羅的に評価します。

5.製品開発およびイノベーション：将来の技術、研究開発活動、画期的な製品開発に関する知的洞察を提供します。

本レポートは、以下のような主要な質問に対応しています：

1.凝固検査市場の市場規模および予測は？

2.凝固検査市場の予測期間中に投資を検討すべき製品、セグメント、用途、分野は何か？

3.凝固検査市場の技術動向と規制枠組みは？

4.凝固検査市場における主要ベンダーの市場シェアは？

5.凝固検査市場への参入に適した形態や戦略的手段は？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • 世界中で凝固障害の罹患率が増加
    • 命を脅かす血栓への意識を高める政府のキャンペーン
  • 抑制要因
    • 凝固検査の払い戻しが不足しています
  • 機会
    • 凝固検査テクノロジーの進歩
    • 在宅ケアのための凝固検査の出現
  • 課題
    • 凝固検査の技術的な制限と不正確さ
• 市場セグメンテーション分析
  • 製品：凝固検査における効率性と拡張性を実現するための自動化機器の導入増加
  • エンドユーザー：遠隔患者モニタリングをサポートする家庭用凝固検査キットの採用が増加
• 市場ディスラプション分析
• ポーターのファイブフォース分析
• バリューチェーンとクリティカルパス分析
• 価格分析
• 技術分析
• 特許分析
• 貿易分析
• 規制枠組みの分析

第6章 凝固検査市場：製品別

• 消耗品
• 機器

第7章 凝固検査市場テストタイプ別

• 活性化部分トロンボプラスチン時間
• プロトロンビン時間
• トロンビン時間

第8章 凝固検査市場：エンドユーザー別

• 臨床検査室
• 家庭での検査
• 病院

第9章 南北アメリカの凝固検査市場

• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第10章 アジア太平洋地域の凝固検査市場

• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第11章 欧州・中東・アフリカの凝固検査市場

• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第12章 競合情勢

• 市場シェア分析2023
• FPNVポジショニングマトリックス, 2023
• 競合シナリオ分析
  • ロシュ社、高まる患者ニーズに応えるため、3つの新しい因子Xa阻害剤凝固検査を発売
  • HORIBA UK、IBMS会議で新型全自動血液凝固分析装置を発表2023
  • ダイアグノスティカ・スタゴ、凝固分析装置でFDA 510（k）認可を取得
• 戦略分析と提言

第13章 競争力のあるポートフォリオ

• 主要企業プロファイル
• 主要製品ポートフォリオ

LIST OF FIGURES

• FIGURE 1. COAGULATION TESTING MARKET RESEARCH PROCESS
• FIGURE 2. COAGULATION TESTING MARKET SIZE, 2023 VS 2030
• FIGURE 3. GLOBAL COAGULATION TESTING MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. GLOBAL COAGULATION TESTING MARKET SIZE, BY REGION, 2023 VS 2030 (%)
• FIGURE 5. GLOBAL COAGULATION TESTING MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. COAGULATION TESTING MARKET DYNAMICS
• FIGURE 7. GLOBAL COAGULATION TESTING MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
• FIGURE 8. GLOBAL COAGULATION TESTING MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 9. GLOBAL COAGULATION TESTING MARKET SIZE, BY TEST TYPE, 2023 VS 2030 (%)
• FIGURE 10. GLOBAL COAGULATION TESTING MARKET SIZE, BY TEST TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 11. GLOBAL COAGULATION TESTING MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
• FIGURE 12. GLOBAL COAGULATION TESTING MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 13. AMERICAS COAGULATION TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 14. AMERICAS COAGULATION TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 15. UNITED STATES COAGULATION TESTING MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 16. UNITED STATES COAGULATION TESTING MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 17. ASIA-PACIFIC COAGULATION TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 18. ASIA-PACIFIC COAGULATION TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 19. EUROPE, MIDDLE EAST & AFRICA COAGULATION TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 20. EUROPE, MIDDLE EAST & AFRICA COAGULATION TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 21. COAGULATION TESTING MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 22. COAGULATION TESTING MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. COAGULATION TESTING MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL COAGULATION TESTING MARKET SIZE, 2018-2023 (USD MILLION)
• TABLE 4. GLOBAL COAGULATION TESTING MARKET SIZE, 2024-2030 (USD MILLION)
• TABLE 5. GLOBAL COAGULATION TESTING MARKET SIZE, BY REGION, 2018-2023 (USD MILLION)
• TABLE 6. GLOBAL COAGULATION TESTING MARKET SIZE, BY REGION, 2024-2030 (USD MILLION)
• TABLE 7. GLOBAL COAGULATION TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 8. GLOBAL COAGULATION TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 9. GLOBAL COAGULATION TESTING MARKET SIZE, BY CONSUMABLES, BY REGION, 2018-2023 (USD MILLION)
• TABLE 10. GLOBAL COAGULATION TESTING MARKET SIZE, BY CONSUMABLES, BY REGION, 2024-2030 (USD MILLION)
• TABLE 11. GLOBAL COAGULATION TESTING MARKET SIZE, BY INSTRUMENTS, BY REGION, 2018-2023 (USD MILLION)
• TABLE 12. GLOBAL COAGULATION TESTING MARKET SIZE, BY INSTRUMENTS, BY REGION, 2024-2030 (USD MILLION)
• TABLE 13. GLOBAL COAGULATION TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
• TABLE 14. GLOBAL COAGULATION TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
• TABLE 15. GLOBAL COAGULATION TESTING MARKET SIZE, BY ACTIVATED PARTIAL THROMBOPLASTIN TIME, BY REGION, 2018-2023 (USD MILLION)
• TABLE 16. GLOBAL COAGULATION TESTING MARKET SIZE, BY ACTIVATED PARTIAL THROMBOPLASTIN TIME, BY REGION, 2024-2030 (USD MILLION)
• TABLE 17. GLOBAL COAGULATION TESTING MARKET SIZE, BY PROTHROMBIN TIME, BY REGION, 2018-2023 (USD MILLION)
• TABLE 18. GLOBAL COAGULATION TESTING MARKET SIZE, BY PROTHROMBIN TIME, BY REGION, 2024-2030 (USD MILLION)
• TABLE 19. GLOBAL COAGULATION TESTING MARKET SIZE, BY THROMBIN TIME, BY REGION, 2018-2023 (USD MILLION)
• TABLE 20. GLOBAL COAGULATION TESTING MARKET SIZE, BY THROMBIN TIME, BY REGION, 2024-2030 (USD MILLION)
• TABLE 21. GLOBAL COAGULATION TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 22. GLOBAL COAGULATION TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 23. GLOBAL COAGULATION TESTING MARKET SIZE, BY CLINICAL LABORATORIES, BY REGION, 2018-2023 (USD MILLION)
• TABLE 24. GLOBAL COAGULATION TESTING MARKET SIZE, BY CLINICAL LABORATORIES, BY REGION, 2024-2030 (USD MILLION)
• TABLE 25. GLOBAL COAGULATION TESTING MARKET SIZE, BY HOME TESTING, BY REGION, 2018-2023 (USD MILLION)
• TABLE 26. GLOBAL COAGULATION TESTING MARKET SIZE, BY HOME TESTING, BY REGION, 2024-2030 (USD MILLION)
• TABLE 27. GLOBAL COAGULATION TESTING MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2023 (USD MILLION)
• TABLE 28. GLOBAL COAGULATION TESTING MARKET SIZE, BY HOSPITALS, BY REGION, 2024-2030 (USD MILLION)
• TABLE 29. AMERICAS COAGULATION TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 30. AMERICAS COAGULATION TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 31. AMERICAS COAGULATION TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
• TABLE 32. AMERICAS COAGULATION TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
• TABLE 33. AMERICAS COAGULATION TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 34. AMERICAS COAGULATION TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 35. AMERICAS COAGULATION TESTING MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
• TABLE 36. AMERICAS COAGULATION TESTING MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
• TABLE 37. ARGENTINA COAGULATION TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 38. ARGENTINA COAGULATION TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 39. ARGENTINA COAGULATION TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
• TABLE 40. ARGENTINA COAGULATION TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
• TABLE 41. ARGENTINA COAGULATION TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 42. ARGENTINA COAGULATION TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 43. BRAZIL COAGULATION TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 44. BRAZIL COAGULATION TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 45. BRAZIL COAGULATION TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
• TABLE 46. BRAZIL COAGULATION TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
• TABLE 47. BRAZIL COAGULATION TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 48. BRAZIL COAGULATION TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 49. CANADA COAGULATION TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 50. CANADA COAGULATION TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 51. CANADA COAGULATION TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
• TABLE 52. CANADA COAGULATION TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
• TABLE 53. CANADA COAGULATION TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 54. CANADA COAGULATION TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 55. MEXICO COAGULATION TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 56. MEXICO COAGULATION TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 57. MEXICO COAGULATION TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
• TABLE 58. MEXICO COAGULATION TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
• TABLE 59. MEXICO COAGULATION TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 60. MEXICO COAGULATION TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 61. UNITED STATES COAGULATION TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 62. UNITED STATES COAGULATION TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 63. UNITED STATES COAGULATION TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
• TABLE 64. UNITED STATES COAGULATION TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
• TABLE 65. UNITED STATES COAGULATION TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 66. UNITED STATES COAGULATION TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 67. UNITED STATES COAGULATION TESTING MARKET SIZE, BY STATE, 2018-2023 (USD MILLION)
• TABLE 68. UNITED STATES COAGULATION TESTING MARKET SIZE, BY STATE, 2024-2030 (USD MILLION)
• TABLE 69. ASIA-PACIFIC COAGULATION TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 70. ASIA-PACIFIC COAGULATION TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 71. ASIA-PACIFIC COAGULATION TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
• TABLE 72. ASIA-PACIFIC COAGULATION TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
• TABLE 73. ASIA-PACIFIC COAGULATION TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 74. ASIA-PACIFIC COAGULATION TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 75. ASIA-PACIFIC COAGULATION TESTING MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
• TABLE 76. ASIA-PACIFIC COAGULATION TESTING MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
• TABLE 77. AUSTRALIA COAGULATION TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 78. AUSTRALIA COAGULATION TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 79. AUSTRALIA COAGULATION TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
• TABLE 80. AUSTRALIA COAGULATION TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
• TABLE 81. AUSTRALIA COAGULATION TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 82. AUSTRALIA COAGULATION TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 83. CHINA COAGULATION TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 84. CHINA COAGULATION TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 85. CHINA COAGULATION TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
• TABLE 86. CHINA COAGULATION TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
• TABLE 87. CHINA COAGULATION TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 88. CHINA COAGULATION TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 89. INDIA COAGULATION TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 90. INDIA COAGULATION TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 91. INDIA COAGULATION TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
• TABLE 92. INDIA COAGULATION TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
• TABLE 93. INDIA COAGULATION TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 94. INDIA COAGULATION TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 95. INDONESIA COAGULATION TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 96. INDONESIA COAGULATION TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 97. INDONESIA COAGULATION TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
• TABLE 98. INDONESIA COAGULATION TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
• TABLE 99. INDONESIA COAGULATION TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 100. INDONESIA COAGULATION TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 101. JAPAN COAGULATION TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 102. JAPAN COAGULATION TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 103. JAPAN COAGULATION TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
• TABLE 104. JAPAN COAGULATION TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
• TABLE 105. JAPAN COAGULATION TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 106. JAPAN COAGULATION TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 107. MALAYSIA COAGULATION TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 108. MALAYSIA COAGULATION TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 109. MALAYSIA COAGULATION TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
• TABLE 110. MALAYSIA COAGULATION TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
• TABLE 111. MALAYSIA COAGULATION TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 112. MALAYSIA COAGULATION TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 113. PHILIPPINES COAGULATION TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 114. PHILIPPINES COAGULATION TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 115. PHILIPPINES COAGULATION TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
• TABLE 116. PHILIPPINES COAGULATION TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
• TABLE 117. PHILIPPINES COAGULATION TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 118. PHILIPPINES COAGULATION TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 119. SINGAPORE COAGULATION TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 120. SINGAPORE COAGULATION TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 121. SINGAPORE COAGULATION TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
• TABLE 122. SINGAPORE COAGULATION TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
• TABLE 123. SINGAPORE COAGULATION TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 124. SINGAPORE COAGULATION TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 125. SOUTH KOREA COAGULATION TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 126. SOUTH KOREA COAGULATION TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 127. SOUTH KOREA COAGULATION TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
• TABLE 128. SOUTH KOREA COAGULATION TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
• TABLE 129. SOUTH KOREA COAGULATION TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 130. SOUTH KOREA COAGULATION TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 131. TAIWAN COAGULATION TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 132. TAIWAN COAGULATION TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 133. TAIWAN COAGULATION TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
• TABLE 134. TAIWAN COAGULATION TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
• TABLE 135. TAIWAN COAGULATION TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 136. TAIWAN COAGULATION TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 137. THAILAND COAGULATION TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 138. THAILAND COAGULATION TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 139. THAILAND COAGULATION TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
• TABLE 140. THAILAND COAGULATION TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
• TABLE 141. THAILAND COAGULATION TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 142. THAILAND COAGULATION TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 143. VIETNAM COAGULATION TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 144. VIETNAM COAGULATION TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 145. VIETNAM COAGULATION TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
• TABLE 146. VIETNAM COAGULATION TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
• TABLE 147. VIETNAM COAGULATION TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 148. VIETNAM COAGULATION TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 149. EUROPE, MIDDLE EAST & AFRICA COAGULATION TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 150. EUROPE, MIDDLE EAST & AFRICA COAGULATION TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 151. EUROPE, MIDDLE EAST & AFRICA COAGULATION TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
• TABLE 152. EUROPE, MIDDLE EAST & AFRICA COAGULATION TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
• TABLE 153. EUROPE, MIDDLE EAST & AFRICA COAGULATION TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 154. EUROPE, MIDDLE EAST & AFRICA COAGULATION TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 155. EUROPE, MIDDLE EAST & AFRICA COAGULATION TESTING MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
• TABLE 156. EUROPE, MIDDLE EAST & AFRICA COAGULATION TESTING MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
• TABLE 157. DENMARK COAGULATION TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 158. DENMARK COAGULATION TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 159. DENMARK COAGULATION TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
• TABLE 160. DENMARK COAGULATION TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
• TABLE 161. DENMARK COAGULATION TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 162. DENMARK COAGULATION TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 163. EGYPT COAGULATION TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 164. EGYPT COAGULATION TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 165. EGYPT COAGULATION TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
• TABLE 166. EGYPT COAGULATION TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
• TABLE 167. EGYPT COAGULATION TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 168. EGYPT COAGULATION TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 169. FINLAND COAGULATION TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 170. FINLAND COAGULATION TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 171. FINLAND COAGULATION TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
• TABLE 172. FINLAND COAGULATION TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
• TABLE 173. FINLAND COAGULATION TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 174. FINLAND COAGULATION TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 175. FRANCE COAGULATION TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 176. FRANCE COAGULATION TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 177. FRANCE COAGULATION TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
• TABLE 178. FRANCE COAGULATION TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
• TABLE 179. FRANCE COAGULATION TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 180. FRANCE COAGULATION TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 181. GERMANY COAGULATION TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 182. GERMANY COAGULATION TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 183. GERMANY COAGULATION TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
• TABLE 184. GERMANY COAGULATION TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
• TABLE 185. GERMANY COAGULATION TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 186. GERMANY COAGULATION TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 187. ISRAEL COAGULATION TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 188. ISRAEL COAGULATION TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 189. ISRAEL COAGULATION TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
• TABLE 190. ISRAEL COAGULATION TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
• TABLE 191. ISRAEL COAGULATION TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 192. ISRAEL COAGULATION TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 193. ITALY COAGULATION TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 194. ITALY COAGULATION TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 195. ITALY COAGULATION TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
• TABLE 196. ITALY COAGULATION TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
• TABLE 197. ITALY COAGULATION TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 198. ITALY COAGULATION TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 199. NETHERLANDS COAGULATION TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 200. NETHERLANDS COAGULATION TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 201. NETHERLANDS COAGULATION TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
• TABLE 202. NETHERLANDS COAGULATION TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
• TABLE 203. NETHERLANDS COAGULATION TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 204. NETHERLANDS COAGULATION TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 205. NIGERIA COAGULATION TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 206. NIGERIA COAGULATION TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 207. NIGERIA COAGULATION TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
• TABLE 208. NIGERIA COAGULATION TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
• TABLE 209. NIGERIA COAGULATION TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 210. NIGERIA COAGULATION TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 211. NORWAY COAGULATION TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 212. NORWAY COAGULATION TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 213. NORWAY COAGULATION TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
• TABLE 214. NORWAY COAGULATION TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
• TABLE 215. NORWAY COAGULATION TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 216. NORWAY COAGULATION TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 217. POLAND COAGULATION TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 218. POLAND COAGULATION TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 219. POLAND COAGULATION TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
• TABLE 220. POLAND COAGULATION TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
• TABLE 221. POLAND COAGULATION TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 222. POLAND COAGULATION TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 223. QATAR COAGULATION TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 224. QATAR COAGULATION TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 225. QATAR COAGULATION TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
• TABLE 226. QATAR COAGULATION TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
• TABLE 227. QATAR COAGULATION TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 228. QATAR COAGULATION TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 229. RUSSIA COAGULATION TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 230. RUSSIA COAGULATION TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 231. RUSSIA COAGULATION TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
• TABLE 232. RUSSIA COAGULATION TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
• TABLE 233. RUSSIA COAGULATION TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 234. RUSSIA COAGULATION TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 235. SAUDI ARABIA COAGULATION TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 236. SAUDI ARABIA COAGULATION TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 237. SAUDI ARABIA COAGULATION TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
• TABLE 238. SAUDI ARABIA COAGULATION TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
• TABLE 239. SAUDI ARABIA COAGULATION TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 240. SAUDI ARABIA COAGULATION TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 241. SOUTH AFRICA COAGULATION TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 242. SOUTH AFRICA COAGULATION TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 243. SOUTH AFRICA COAGULATION TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
• TABLE 244. SOUTH AFRICA COAGULATION TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
• TABLE 245. SOUTH AFRICA COAGULATION TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 246. SOUTH AFRICA COAGULATION TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 247. SPAIN COAGULATION TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 248. SPAIN COAGULATION TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 249. SPAIN COAGULATION TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
• TABLE 250. SPAIN COAGULATION TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
• TABLE 251. SPAIN COAGULATION TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 252. SPAIN COAGULATION TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 253. SWEDEN COAGULATION TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 254. SWEDEN COAGULATION TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 255. SWEDEN COAGULATION TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
• TABLE 256. SWEDEN COAGULATION TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
• TABLE 257. SWEDEN COAGULATION TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 258. SWEDEN COAGULATION TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 259. SWITZERLAND COAGULATION TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 260. SWITZERLAND COAGULATION TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 261. SWITZERLAND COAGULATION TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
• TABLE 262. SWITZERLAND COAGULATION TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
• TABLE 263. SWITZERLAND COAGULATION TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 264. SWITZERLAND COAGULATION TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 265. TURKEY COAGULATION TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 266. TURKEY COAGULATION TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 267. TURKEY COAGULATION TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
• TABLE 268. TURKEY COAGULATION TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
• TABLE 269. TURKEY COAGULATION TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 270. TURKEY COAGULATION TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 271. UNITED ARAB EMIRATES COAGULATION TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 272. UNITED ARAB EMIRATES COAGULATION TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 273. UNITED ARAB EMIRATES COAGULATION TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
• TABLE 274. UNITED ARAB EMIRATES COAGULATION TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
• TABLE 275. UNITED ARAB EMIRATES COAGULATION TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 276. UNITED ARAB EMIRATES COAGULATION TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 277. UNITED KINGDOM COAGULATION TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 278. UNITED KINGDOM COAGULATION TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 279. UNITED KINGDOM COAGULATION TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
• TABLE 280. UNITED KINGDOM COAGULATION TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
• TABLE 281. UNITED KINGDOM COAGULATION TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 282. UNITED KINGDOM COAGULATION TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 283. COAGULATION TESTING MARKET SHARE, BY KEY PLAYER, 2023
• TABLE 284. COAGULATION TESTING MARKET, FPNV POSITIONING MATRIX, 2023

[192 Pages Report] The Coagulation Testing Market size was estimated at USD 4.62 billion in 2023 and expected to reach USD 5.07 billion in 2024, at a CAGR 9.92% to reach USD 8.96 billion by 2030.

Coagulation testing encompasses a range of diagnostic procedures aimed at assessing the blood's ability to clot properly. These tests are critical in diagnosing and managing various conditions that affect the blood's clotting capability, such as hemophilia, thrombosis, and liver disease. They are also essential in monitoring patients on anticoagulation therapy to ensure safe and effective treatment outcomes. The rising prevalence of cardiovascular diseases and blood disorders has increased the adoption of coagulation testing. Additionally, the aging global population at higher risk of blood-related disorders also significantly raises the need for coagulation testing. However, the high cost of coagulation testing devices and stringent regulatory requirements for the new devices' approval delay product launches, affecting market dynamics. Despite these challenges, increasing investment in healthcare infrastructure in emerging economies provides a future growth prospect. Furthermore, ongoing research and development activities aiming to introduce innovative and efficient coagulation testing solutions are expected to offer new avenues for expansion.

Product: Rising deployment of automated instruments to achieve efficiency and scalability in coagulation testing

Consumables in coagulation testing include reagents, test strips, and other single-use materials integral to conducting a coagulation test. These are essential for accurately detecting and measuring blood clotting times, factors, and other related parameters. Coagulation testing instruments range from basic manual devices to fully automated systems. These machines are used for various tests such as Prothrombin Time (PT), Activated Partial Thromboplastin Time (aPTT), and more. The choice between manual and automated systems is generally based on the volume of tests a laboratory performs and the complexity of the tests required.

End-User: Growing adoption of home coagulation testing kits to support remote patient monitoring

Clinical laboratories represent a significant segment of the coagulation testing market. These facilities require comprehensive and advanced coagulation testing solutions to offer accurate and reliable diagnostic services for a variety of bleeding and clotting disorders. The preference in clinical laboratories leans towards high-throughput coagulation analyzers that can handle a large volume of samples efficiently. The demand for home testing solutions in coagulation testing has surged, driven by the increasing emphasis on patient-centered care and the need for continuous monitoring of patients on anticoagulation therapy. Home testing kits appeal to patients seeking convenience and minimal disruption to daily life. Hospitals require a diverse range of coagulation testing capabilities to cater to the needs of different departments, from emergency rooms to specialized coagulation clinics. The preference in this segment is for versatile and rapid coagulation analyzers that facilitate quick decision-making in acute care settings.

Regional Insights

In the Americas, coagulation testing is getting highly adopted owing to the high prevalence of cardiovascular diseases and an increasing aging population, particularly in North America. The United States showcases higher adoption, supported by advanced healthcare infrastructure and favorable reimbursement policies. The EMEA region presents diverse scenarios in the coagulation testing market, with Europe having a high adoption rate. The growth in Europe is spurred by the increasing adoption of point-of-care (POC) testing devices for faster and more efficient diagnosis, alongside strong healthcare systems and a higher level of patient awareness. The Middle East and Africa are witnessing gradual growth, with initiatives by governments and NGOs to improve healthcare facilities. Asia-Pacific is projected to be the biggest market for coagulation testing, driven by rapidly developing healthcare infrastructure and a large patient pool. Countries inclduing China and India are at the forefront of the adoption of coagulation testing, with their growing middle-class populations and increased focus on healthcare reform. Furthermore, the expanding research and development activities in the region to develop affordable testing solutions are expected to boost the market in this region.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Coagulation Testing Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Coagulation Testing Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Coagulation Testing Market, highlighting leading vendors and their innovative profiles. These include A&T Corporation, Abbott Laboratories, Advin Health Care, Becton, Dickinson and Company, Beijing Succeeder Technology Inc., Bio Group Medical System SRL, Bio-Rad Laboratories, Inc., Coagulation Sciences LLC, Danaher Corporation, Drucker Diagnostics, LLC, F. Hoffmann-La Roche Ltd, Genrui Biotech Inc., Helena Laboratories Corporation, HORIBA, Ltd., Maccura Biotechnology Co., Ltd., Medtronic PLC, Mindray Bio-Medical Electronics Co., Ltd., Sekisui Chemical Co., Ltd., Shenzhen Micropoint Biotechnologies Co., Ltd., Siemens Healthineers AG, Stago Group, Sysmex Corporation, Thermo Fisher Scientific Inc., Trivitron Healthcare, and Tulip Diagnostics (P) Ltd.

Market Segmentation & Coverage

This research report categorizes the Coagulation Testing Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Product
  • Consumables
  • Instruments

• Test Type
  • Activated Partial Thromboplastin Time
  • Prothrombin Time
  • Thrombin Time

• End-User
  • Clinical Laboratories
  • Home Testing
  • Hospitals

• Region
  • Americas
    • Argentina
    • Brazil
    • Canada
    • Mexico
    • United States
      • California
      • Florida
      • Illinois
      • New York
      • Ohio
      • Pennsylvania
      • Texas
  • Asia-Pacific
    • Australia
    • China
    • India
    • Indonesia
    • Japan
    • Malaysia
    • Philippines
    • Singapore
    • South Korea
    • Taiwan
    • Thailand
    • Vietnam

• Europe, Middle East & Africa
  • Denmark
  • Egypt
  • Finland
  • France
  • Germany
  • Israel
  • Italy
  • Netherlands
  • Nigeria
  • Norway
  • Poland
  • Qatar
  • Russia
  • Saudi Arabia
  • South Africa
  • Spain
  • Sweden
  • Switzerland
  • Turkey
  • United Arab Emirates
  • United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.

2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.

3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.

4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.

5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the Coagulation Testing Market?

2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Coagulation Testing Market?

3. What are the technology trends and regulatory frameworks in the Coagulation Testing Market?

4. What is the market share of the leading vendors in the Coagulation Testing Market?

5. Which modes and strategic moves are suitable for entering the Coagulation Testing Market?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Increasing prevalence of coagulation disorders worldwide
    • 5.1.1.2. Government campaigns promoting awareness of life-threatening blood clots
  • 5.1.2. Restraints
    • 5.1.2.1. Lack of reimbursements for coagulation testing
  • 5.1.3. Opportunities
    • 5.1.3.1. Advancements in coagulation testing technologies
    • 5.1.3.2. Emergence of coagulation testing for homecare
  • 5.1.4. Challenges
    • 5.1.4.1. Technical limitations and inaccuracies of coagulation testing
• 5.2. Market Segmentation Analysis
  • 5.2.1. Product: Rising deployment of automated instruments to achieve efficiency and scalability in coagulation testing
  • 5.2.2. End-User: Growing adoption of home coagulation testing kits to support remote patient monitoring
• 5.3. Market Disruption Analysis
• 5.4. Porter's Five Forces Analysis
  • 5.4.1. Threat of New Entrants
  • 5.4.2. Threat of Substitutes
  • 5.4.3. Bargaining Power of Customers
  • 5.4.4. Bargaining Power of Suppliers
  • 5.4.5. Industry Rivalry
• 5.5. Value Chain & Critical Path Analysis
• 5.6. Pricing Analysis
• 5.7. Technology Analysis
• 5.8. Patent Analysis
• 5.9. Trade Analysis
• 5.10. Regulatory Framework Analysis

6. Coagulation Testing Market, by Product

• 6.1. Introduction
• 6.2. Consumables
• 6.3. Instruments

7. Coagulation Testing Market, by Test Type

• 7.1. Introduction
• 7.2. Activated Partial Thromboplastin Time
• 7.3. Prothrombin Time
• 7.4. Thrombin Time

8. Coagulation Testing Market, by End-User

• 8.1. Introduction
• 8.2. Clinical Laboratories
• 8.3. Home Testing
• 8.4. Hospitals

9. Americas Coagulation Testing Market

• 9.1. Introduction
• 9.2. Argentina
• 9.3. Brazil
• 9.4. Canada
• 9.5. Mexico
• 9.6. United States

10. Asia-Pacific Coagulation Testing Market

• 10.1. Introduction
• 10.2. Australia
• 10.3. China
• 10.4. India
• 10.5. Indonesia
• 10.6. Japan
• 10.7. Malaysia
• 10.8. Philippines
• 10.9. Singapore
• 10.10. South Korea
• 10.11. Taiwan
• 10.12. Thailand
• 10.13. Vietnam

11. Europe, Middle East & Africa Coagulation Testing Market

• 11.1. Introduction
• 11.2. Denmark
• 11.3. Egypt
• 11.4. Finland
• 11.5. France
• 11.6. Germany
• 11.7. Israel
• 11.8. Italy
• 11.9. Netherlands
• 11.10. Nigeria
• 11.11. Norway
• 11.12. Poland
• 11.13. Qatar
• 11.14. Russia
• 11.15. Saudi Arabia
• 11.16. South Africa
• 11.17. Spain
• 11.18. Sweden
• 11.19. Switzerland
• 11.20. Turkey
• 11.21. United Arab Emirates
• 11.22. United Kingdom

12. Competitive Landscape

• 12.1. Market Share Analysis, 2023
• 12.2. FPNV Positioning Matrix, 2023
• 12.3. Competitive Scenario Analysis
  • 12.3.1. Roche Launches Three New Factor Xa Inhibitor Coagulation Tests to Meet Growing Patient Need
  • 12.3.2. HORIBA UK to Introduce New Fully Automated Haemostasis Analysers at IBMS Congress 2023
  • 12.3.3. Diagnostica Stago Nabs FDA 510(k) Clearance for Coagulation Analyzers
• 12.4. Strategy Analysis & Recommendation

13. Competitive Portfolio

• 13.1. Key Company Profiles
• 13.2. Key Product Portfolio